Mourad Zerfaoui
- Biological Psychiatry top 5%
- Immunology top 10%
- Oncology top 5%
- PARP inhibition in cancer therapy 11
- Physiology top 5%
- Cancer Research top 10%
- NF-κB Signaling Pathways 4
- MicroRNA in disease regulation 3
-
- Thyroid Cancer Diagnosis and Treatment 8
-
- Cell Adhesion Molecules Research 6
-
- Glycosylation and Glycoproteins Research 5
- Melanoma and MAPK Pathways 3
-
- Ion Channels and Receptors 5
- Co-authors
- A. Hamid BoularesAmarjit S. NauraChetan P. HansYoussef ErramiZakaria Y. Abd ElmageedCharles D. NicholsKhalid MatrouguiJaime Becnel
- Journals
- Journal of Biological Chemistry (2 papers)Circulation (1 paper)The Journal of Immunology (4 papers)
- Partner nations
- United StatesEgyptFrance
In The Last Decade
Mourad Zerfaoui
48 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 112
- Biological Psychiatry 74
- Immunology 388
- Oncology 469
- Physiology 76
- Cancer Research 181
Countries citing papers authored by Mourad Zerfaoui
This map shows the geographic impact of Mourad Zerfaoui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mourad Zerfaoui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mourad Zerfaoui more than expected).
Fields of papers citing papers by Mourad Zerfaoui
This network shows the impact of papers produced by Mourad Zerfaoui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mourad Zerfaoui. The network helps show where Mourad Zerfaoui may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mourad Zerfaoui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 5 | |
| 2 | 2023 | 3 | |
| 3 | 2022 | 9 | |
| 4 | 2022 | 10 | |
| 5 | 2019 | 21 | |
| 6 | 2012 | 42 | |
| 7 | 2011 | 1 | |
| 8 | 2011 | 72 | |
| 9 | 2010 | 21 | |
| 10 | 2010 | 42 | |
| 11 | 2009 | 44 | |
| 12 | Abstract 1685: Thieno[2,3-c]isoquinolin-5-one (TIQ-A), a Potent Poly(ADP-ribose) Polymerase Inhibitor, Promotes Atherosclerotic Plaque Regression in High Fat Diet-fed ApoE-deficient Mice: Effects on Inflammatory Markers and Lipid Content | 2008 | 1 |
| 13 | 2008 | 36 | |
| 14 | 2008 | 42 | |
| 15 | 2008 | 173 | |
| 16 | Activation and Nuclear translocation of p65 NF-kappaB are sufficient for VCAM-1, but insufficient for ICAM-1, expression in TNF-stimulated primary smooth muscle cells: differential requirement for PARP-1 expression and interaction | 2007 | 18 |
| 17 | 2007 | 14 | |
| 18 | 2002 | 37 | |
| 19 | 1999 | 17 | |
| 20 | 1998 | 1 |
About Mourad Zerfaoui
Mourad Zerfaoui is a scholar working on Sensory Systems, Immunology and Allergy and Cancer Research, having authored 49 papers that have together received 1.5k indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (11 papers), Thyroid Cancer Diagnosis and Treatment (8 papers), Cell Adhesion Molecules Research (6 papers), Glycosylation and Glycoproteins Research (5 papers), Ion Channels and Receptors (5 papers), NF-κB Signaling Pathways (4 papers), MicroRNA in disease regulation (3 papers) and Melanoma and MAPK Pathways (3 papers). The work is most often cited by research in Biological Psychiatry (74 citations), Immunology (388 citations) and Oncology (469 citations). Mourad Zerfaoui has collaborated with scholars based in United States, Egypt and France. Frequent co-authors include A. Hamid Boulares, Amarjit S. Naura, Chetan P. Hans, Youssef Errami, Zakaria Y. Abd Elmageed, Charles D. Nichols, Khalid Matrougui, Jaime Becnel, Hogyoung Kim and Bangning Yu. Their work appears in journals such as Journal of Biological Chemistry, Circulation and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.